Zheng Zhang, Ph.D.

Head of Cell Line Development at BeOne Medicines

Speaker

Dr. Zheng Zhang joined BeOne Medicines in 2022, and currently is leading Cell Line Development. He and his team continuously innovating and optimizing the cell line platforms, to express various modalities with greater productivity, higher product quality, and better stability, using cutting-edge molecular and cellular technologies. He also serves as the technical lead of several integrated CMC programs to provide technical oversight and project management. Prior to joining BeOne Medicines, he was the Cell Line Development Director at WuXi Biologics. Dr. Zhang obtained his Ph.D. in Molecular Biology from University of Southern California and authored multiple peer-reviewed articles in the pharmaceutical field.